Home
Matthew K. Fust, Director: Crinetics Pharmaceuticals CRNX Sell · Filed 25/09/30
Trade details
- Type
- Insider sale
- Amount
- $716,000
- Shares · price
- 16,000 sh · $44.75 a share
- Held after
- 22,836 sh
- Person
- Matthew K. FustDirector
- Trade date
- 25/09/26
- Filed
- 25/09/30
- Days to filing
- 4 days
Sold 41.2% of holdings
- Share of holding sold
- 41.2%
Crinetics Pharmaceuticals trades, last 26 weeks
What else happened in Crinetics Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 25/08/27~25/10/26Matthew K. Fust's recent trades
- Matthew K. Fust
Sell10b5-1 planNeumora Therapeutics
Sell10b5-1 planNeumora Therapeutics
NMRA
$239.3K
14,049 sh
$239.3K
Filed 24/10/18
Traded 24/10/18
- Matthew K. Fust
Sell10b5-1 planNeumora Therapeutics
Sell10b5-1 planNeumora Therapeutics
NMRA
$131.6K
7,739 sh
$131.6K
Filed 24/10/18
Traded 24/10/17
- Matthew K. Fust
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 planCrinetics Pharmaceuticals
CRNX
$796.3K
17,500 sh
$796.3K
Filed 24/03/22
Traded 24/03/20
- Matthew K. Fust
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 planCrinetics Pharmaceuticals
CRNX
$762.7K
17,500 sh
$762.7K
Filed 24/03/22
Traded 24/03/20
- Matthew K. Fust
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 planCrinetics Pharmaceuticals
CRNX
$544.6K
12,500 sh
$544.6K
Filed 24/03/22
Traded 24/03/20
